Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$18,027,434
+$5,301,497 QoQ
Shares Held
15,030
+8.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#937
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $80,207,351 across 13 Drug Manufacturers - General names. LLY ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,358 | $19,466,367 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
15,030 | $18,027,434 | |
| 3 | JNJ |
Johnson & Johnson
|
53,587 | $13,609,490 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,604 | $10,229,114 | |
| 5 | AMGN |
Amgen Inc
|
14,339 | $5,192,438 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
40,890 | $5,166,042 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,891 | $3,047,579 | |
| 8 | PFE |
Pfizer Inc
|
103,774 | $2,498,877 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,027,434 | 15,030 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $12,725,937 | 13,836 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $14,849,929 | 13,818 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $8,494,479 | 11,133 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $7,871,693 | 10,098 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $8,071,618 | 9,773 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,300,804 | 9,457 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,008,011 | 9,039 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $6,610,326 | 8,497 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $4,032,057 | 6,917 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,784,890 | 10,770 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $1,881,078 | 4,011 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,045,370 | 3,044 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,291,049 | 3,529 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,116,527 | 3,453 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,257,363 | 3,878 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $695,306 | 2,428 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $467,916 | 1,694 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $355,817 | 1,540 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $407,398 | 1,775 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $495,259 | 2,651 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $318,601 | 1,887 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $271,468 | 1,834 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $868,348 | 5,289 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $549,053 | 3,958 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||